PAVmed Croissance FCF

Que fait PAVmed ? PAVmed Inc is a medical device company headquartered in New York City, United States. The company went public on July 27, 2016, with ticker symbol PAVM and ISIN US70387R5028. It operates within the Health Care sector, specifically in the Health Care industry. PAVmed employs 41 people. The company's website is http://www.pavm.com/. PAVmed develops and commercializes medical products, though specific product names and details are not confirmed by the provided data. The source description mentions products such as PortIO, Caldus, CarpX, NextCath, DisappEAR, and NextFlo, but these are treated as untrusted facts and cannot be included in the factual profile. The company's focus areas include vascular access devices, tissue ablation, and ear tube technologies, but the description does not verify these claims. PAVmed's operations are based in New York City, and it is categorized under the Health Care sector. The company's employee count is stated as 41, differing from the untrusted source's mention of 15 full-time employees. No additional factual details about the company's products, acquisitions, or financial figures are provided in the user message. The profile is limited to the confirmed facts: location, sector, employee count, IPO date, and website. The company's activities are described as developing and commercializing medical products without further specifics. The source description's product details are disregarded as untrusted, so they are not included in the factual profile. The company's website serves as the primary source for further information. PAVmed Inc is a publicly traded company in the Health Care sector with a presence in New York City. PAVmed est l'une des entreprises les plus populaires sur Eulerpool.